Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Share price
View:
Post by HighteawithIntrepid on Dec 25, 2014 4:23pm

Share price

Sorry SWNE

DS2*2⃣

Every day there is a bid and an ask and we
 have been trading in a range of .20 to.23.
So for TFSA top up trades that is the market 
price.
Anyone experiencing a margin call forced sale
would have to take less than our range.
Anyone wanting to buy a large block would 
have to pay more than our range.
Someone wanting to take us over for our patents 
and tax losses would have to pay more than a block trade.
Once we get some future good news the range
 should move up. Actually filing to the FDA will 
be considered good news by the market.
Getting a thumbs up from the FDA will be the 10 
bagger. But getting a thumbs down is the equivalent  
of tripping at the finish line.
Yes we win No we loose. I don't see any middle ground here.
If anyone sees an outcome other than a yes or no from the FDA let's 
hear it.
Which is why investing is about owning a basket of stocks and
letting your winners run and fighting the urge to average down.
It is that urge to double down that usually bites us. Here is hoping 
that isn't the case with TST as most of us have averaged down more 
than once.

Here is to this ⬆️ Not this ⬇️ From the FDA 
ASAP in 2015.

HT
Comment by beechguy on Dec 29, 2014 10:33am
I bought another 60k this month, so I guess the averaging down talk is falling on deaf ears. I also disagree with your yes and no theory with the FDA. We could also get bought out, get a partner with big up front funds, we can start a Oncocidin Human trial with those funds. It has market potential in the multiple billions. We can sell our VMC plant or partner with a vaccine manufacturer. A full ...more  
Comment by Tson99 on Dec 29, 2014 11:33am
Hey Beech, I've been buying too. I don't think we will be going much lower. We were supposed to have a couple of analysts on-board by year end, new website, and new marketing campaigne started but management propbably decided to wait until the new year. Who knows this could be the last week in the 20's. Cheers, Tson99
Comment by beechguy on Dec 29, 2014 11:58am
I hope they don't come out with an analyst report this week. That would be too Graeme like. Let the traders get back to their desk and hit the buyers before the Christmas CC bills come in. Lets hope it is a TD, RBC, Cannacord etc and not the clowns Bioniche used a couple of years ago. We should also be getting the independent study on market size insurance coverage etc shortly. Very interested ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities